Additionally, gallbladder imaging and appropriate follow-up should be considered in cases suggestive of cholelithiasis, particularly in the context of rapid weight loss [12, 64, 94]
For example, AstraZeneca (AZ) has recently signed an exclusive license agreement with Eccogene granting it certain exclusive global rights for Eccogenes oral GLP-1RA drug in development
People treated with a high dose lost an average of 24 percent of their body weight after nearly a year of treatment, a small clinical trial reported this year
Pharmaceutical GLP-1 medications solved this problem through molecular engineering
I.ZirintundaG.AslamA.et al (2021)
We believe in a partnership approach, where your questions are always welcome, and your progress is continuously monitored